Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer

Cancer Biomarkers

Volumn 17, Issue 2, 2016, Pages 187-194

  Zhang, Kaijiong ^a   Luo, Zhenglian ^a   Zhang, Yi ^a   Zhang, Li ^b   Wu, Lichun ^b   Liu, Lian ^a   Yang, Jie ^a   Song, Xiaoyu ^b   Liu, Jinbo ^a  

^a THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

Breast cancer; LncRNA H19; Plasma biomarker

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; RNA H19; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; ADULT; AGED; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; GENETICS; METASTASIS; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RNA, LONG NONCODING; ROC CURVE;

EID: 84981713500     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-160630     Document Type: Article

References (46)

1. L. A. Torre, F. Bray, R. L. Siegel, et al., Global cancer statistics, 2012, CA Cancer J Clin 65 (2015), 87-108.
2. R. Siegel, D. Naishadham and A. Jemal, Cancer statistics, CA Cancer J Clin 63 (2013), 11-30.
3. M. J. Duffy, D. Evoy and E. W. McDermott, CA 15-3: uses and limitation as a biomarker for breast cancer, Clin Chim Acta 411 (2010), 1869-1874.
4. N. Patani, L. A. Martin and M. Dowsett, Biomarkers for the clinical management of breast cancer: international perspective, Int J Cancer 133 (2013), 1-13.
5. S. van Heesch, M. van Iterson, J. Jacobi, et al., Extensive localization of long noncoding RNAs to the cytosol and monoand polyribosomal complexes, Genome Biol 15 (2014), R6.
6. J. Tantai, D. Hu, Y. Yang, et al., Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer, Int J Clin Exp Pathol 8 (2015), 7887-7895.
7. Y. J. Su, J. Yu, Y. Q. Huang, et al., Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer, Int J Mol Sci 16 (2015), 13322-13338.
8. M. M. Kamel, M. Matboli, M. Sallam, et al., Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma, Transl Res 168 (2016), 134-145.
9. J. Gao, R. Cao and H. Mu, Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer, Int J Clin Exp Pathol 8 (2015), 12936-12942.
10. W. Wei, J. Leng, H. Shao, et al., High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients, Int J Clin Exp Med 8 (2015), 16606-16612.
11. N. Xu, F. Chen, F. Wang, et al., Clinical significance of high expression of circulating serum lncRNA RP11-445H22. 4 in breast cancer patients: a Chinese population-based study, Tumour Biol 36 (2015), 7659-7665.
12. L. Zhang, X. Song, X. Wang, et al., Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer, Breast Cancer Res Treat 152 (2015), 199-208.
13. A. Gabory, H. Jammes and L. Dandolo, The H19 locus: role of an imprinted non-coding RNA in growth and development, Bioessays 32 (2010), 473-480.
14. N. Giannoukakis, C. Deal, J. Paquette, et al., Parental genomic imprinting of the human IGF2 gene, Nat Genet 4 (1993), 98-101.
15. T. Dugimont, J. J. Curgy, N. Wernert, et al., The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas, Biol Cell 85 (1995), 117-124.
16. E. Adriaenssens, S. Lottin, T. Dugimont, et al., Steroid hormones modulate H19 gene expression in both mammary gland and uterus, Oncogene 18 (1999), 4460-4473.
17. J. Liu, A. I. Kahri, P. Heikkila, et al., H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells, J Clin Endocrinol Metab 80 (1995), 492-496.
18. H. Soejima and K. Higashimoto, Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders, J Hum Genet 58 (2013), 402-409.
19. M. Zhu, Q. Chen, X. Liu, et al., lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI, FEBS J 281 (2014), 3766-3775.
20. M. Luo, Z. Li, W. Wang, et al., Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression, Cancer Lett 333 (2013), 213-221.
21. H. Li, B. Yu, J. Li, et al., Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer, Oncotarget 5 (2014), 2318-2329.
22. L. Wang, Y. Cai, X. Zhao, et al., Down-regulated long noncoding RNA H19 inhibits carcinogenesis of renal cell carcinoma, Neoplasma 62 (2015), 412-418.
23. I. J. Matouk, E. Raveh, R. Abu-lail, et al., Oncofetal H19 RNA promotes tumor metastasis, Biochim Biophys Acta 1843 (2014), 1414-1426.
24. C. Vennin, N. Spruyt, F. Dahmani, et al., H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b, Oncotarget 6 (2015), 29209-29223.
25. X. Zhou, C. Yin, Y. Dang, et al., Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer, Sci Rep 5 (2015), 11516.
26. L. Dong, P. Qi, M. D. Xu, et al., Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls, Int J Cancer 137 (2015), 1128-1135.
27. K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25 (2001), 402-408.
28. S. J. Dawson, D. W. Tsui, M. Murtaza, et al., Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med 368 (2013), 1199-1209.
29. C. Kohler, Z. Barekati, R. Radpour, et al., Cell-free DNA in the circulation as a potential cancer biomarker, Anticancer Res 31 (2011), 2623-2628.
30. J. Wang, K. Y. Zhang, S. M. Liu, et al., Tumor-associated circulating microRNAs as biomarkers of cancer, Molecules 19 (2014), 1912-1938.
31. O. Shaker, M. Maher, Y. Nassar, et al., Role of microRNAs-29b-2,-155,-197 and-205 as diagnostic biomarkers in serum of breast cancer females, Gene 560 (2015), 77-82.
32. G. Bertoli, C. Cava and I. Castiglioni, MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer, Theranostics 5 (2015), 1122-1143.
33. X. R. Yang, J. Chang-Claude, E. L. Goode, et al., Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies, J Natl Cancer Inst 103 (2011), 250-263.
34. E. Adriaenssens, L. Dumont, S. Lottin, et al., H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression, Am J Pathol 153 (1998), 1597-1607.
35. H. Sun, G. Wang, Y. Peng, et al., H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells, Oncol Rep 33 (2015), 3045-3052.
36. P. Basak, S. Chatterjee, S. Weger, et al., Estrogen regulates luminal progenitor cell differentiation through H19 gene expression, Endocr Relat Cancer 22 (2015), 505-517.
37. D. P. English, D. M. Roque and A. D. Santin, HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies, Mol Diagn Ther 17 (2013), 85-99.
38. H. Schwarzenbach, D. S. Hoon and K. Pantel, Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer 11 (2011), 426-437.
39. M. van der Vaart and P. J. Pretorius, Circulating DNA. Its origin and fluctuation, Ann N Y Acad Sci 1137 (2008), 18-26.
40. M. Stroun, P. Maurice, V. Vasioukhin, et al., The origin and mechanism of circulating DNA, AnnN YAcad Sci 906 (2000), 161-168.
41. L. Han, P. Ma, S. M. Liu, et al., Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects, Tumour Biol (2015).
42. T. Kogure, I. K. Yan, W. L. Lin, et al., Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer, Genes Cancer 4 (2013), 261-272.
43. K. Takahashi, I. K. Yan, T. Kogure, et al., Extracellular vesiclemediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer, FEBS Open Bio 4 (2014), 458-467.
44. Y. J. Jiang and D. D. Bikle, LncRNA: a new player in 1alpha, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation, Exp Dermatol 23 (2014), 147-150.
45. A. Conigliaro, V. Costa, A. LoDico, et al., CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA, Mol Cancer 14 (2015), 155.
46. Z. F. Yang, P. Ngai, D. W. Ho, et al., Identification of local and circulating cancer stem cells in human liver cancer, Hepatology 47 (2008), 919-928.